Inventiva announces shareholder meeting notice

• Inventiva will hold an ordinary and extraordinary general meeting in Paris on June 30, 2026.
• Shareholders will vote on the 2025 statutory and consolidated financial statements, the allocation of a EUR 207.97 million net loss, and approval of a share subscription agreement with Samsara BioCapital.
• Items include executive and board pay votes, board refresh proposals with two director renewals and three director appointments, and authorization for a share buyback program with a maximum purchase price of EUR 40 per share.
• Capital measures up for approval include authority to cancel repurchased shares, multiple mandates to issue shares or securities with or without preemptive rights, and an “at-the-market” issuance program in the form of American Depositary Shares or American Depositary Receipts.
• Other proposals cover employee equity incentives, issuance of 2026 share subscription warrants, a vote to continue operations despite shareholders’ equity falling below half of share capital, and amendments to the articles of association.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Inventiva SA published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-065699), on May 22, 2026, and is solely responsible for the information contained therein.